ReviewDrugs2026
More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases.
Lucia Del Vecchio et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewDrugs2026
Lucia Del Vecchio et al.PubMed ↗Publisher ↗
No numbers read from the abstract.